TYROSINE KINASE INHIBITORS AND PREGNANCY
The management of patients with chronic myeloid leukemia (CML) during pregnancy has became recently a matter of continuous debate. The introduction of the Tyrosine Kinase Inhibitors (TKIs) in clinical practice has dramatically changed the prognosis of CML patients. Patients diagnosed in chronic ph...
Saved in:
| Main Authors: | Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2014-04-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/1362 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection
by: Elisabetta Abruzzese, et al.
Published: (2020-04-01) -
Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.
by: Stefano Fratoni, et al.
Published: (2013-02-01) -
TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01) -
Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
by: Evan Pisick, et al.
Published: (2004-01-01) -
Pharmacovigilance study of tyrosine kinase inhibitors: Analysis of adverse reactions
by: Antoan Rangelov, et al.
Published: (2024-11-01)